On January 14th, in a transaction on Tuesday, Summit Therapeutics PLC (LON:SUMM) insider Robert W. Duggan made a sale of 33,321,870 shares of the Summit Therapeutics stock. For a total transaction of £7,330,811.40 ($9,643,266.77), the sale was made at an average price of GBX 22 ($0.29).
On friday, an opening up of the shares of LON SUMM happened at GBX 21 ($0.28). Summit Therapeutics PLC possesses a 52 week high of GBX 34.67 ($....
Tags : Summit Therapeutics Company, ,
comments (0)